Additive Benefit of Guideline-Directed Medical Therapies at Discharge in Reducing 30-Day Readmissions in Heart Failure

Background: Hospitalization-related costs for heart failure (HF) are a major contributor to the overall health care expenditure in the United States. Despite recommendations, guideline-directed medical therapy (GDMT) is underutilized at discharge in eligible patients, likely contributing to high rea...

詳細記述

書誌詳細

主要な著者:	Andrew Willeford, PharmD, PhD, Barry Greenberg, MD, Zaid Yousif, PharmD, MAS
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2026-01-01
シリーズ:	JACC: Advances
主題:	guideline-directed medical therapy heart failure hospital readmission patient discharge registries
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2772963X25008415
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!